Search
AxoGen Inc
AXGNAdd to Watchlist
50.020USD
+1.270+2.61%
Close 11-06 16:00（ET）
2.99BMarket Cap
LossP/E TTM
After-hours 17:36 (ET)49.900USD-0.100-0.20%
After-hours 17:36 (ET)AxoGen Inc (AXGN) Stock Price Target & Forecast
Analyst Rating
Based on 10 analysts giving stock ratings to AxoGen Inc in the past month.
Buy
2 Strong Buy
8 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
59.091USD+19.69%
AXGN Analyst Recommendation Trends
In the current month, AXGN has received 8 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. AXGN average Analyst price target in the last month is 59.091.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2
2
2
2
2
2
2
2
8
8
7
8
8
8
8
9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10
10
9
10
10
10
10
11
AXGN Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Intuitive Surgical Inc
ISRG
11
13
9
1
0
34
Boston Scientific Corp
BSX
7
15
11
0
0
33
Thermo Fisher Scientific Inc
TMO
10
17
3
0
0
30
Edwards Lifesciences Corp
EW
10
14
6
0
0
30
Veeva Systems Inc
VEEV
8
13
7
1
0
29
Danaher Corp
DHR
11
13
3
0
0
27
Waters Corp
WAT
8
10
8
0
0
26
Agilent Technologies Inc
A
6
11
7
0
0
24
GE Healthcare Technologies Inc
GEHC
6
10
7
0
0
23
Resmed Inc
RMD
3
8
10
1
1
23
Financial Forecasting
Based on analysts' estimates, AXGN EPS is projected to reach 0.150 in FY2026Q4, following reported EPS of 0.042 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
Forecast
0.07
0.12
0.14
0.15
0.15
Actual
-0.38
-0.03
0.04
--
--
Surprise
-628.25%
-123.40%
-69.28%
--
--
FAQs
What is AxoGen Inc's expected revenue for the next quarter?
AxoGen Inc's expected revenue is 81.78M.
What is AxoGen Inc's price target?
Analysts forecast that AxoGen Inc's price target is USD 59.09, with the highest forecast at USD 65.00 and the lowest forecast at USD 56.00.
How have AxoGen IncAXGN's recent earnings per share performed?
The market expectation was USD 0.04, while AxoGen IncAXGN's earnings per share (EPS) for the previous quarter was USD -0.03. EPS for the next quarter is expected at USD 0.15.
What is the analyst rating for AxoGen Inc?
Based on the ratings of AxoGen Inc's stock from 10 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.